Compare CPM-RMI trial: intramyocardial transplantation of autologous bone marrow-derived cd133+ cells and mononuclear cells during coronary artery bypass grafting in patients with recent myocardial infarction: a phase II/III, multicenter, placebo-controlled, randomized, double-blind clinical trial
Cell Journal [Yakhteh]. 2018; 20 (2): 267-277
em Inglês
| IMEMR
| ID: emr-198738
ABSTRACT
Objective:
The regenerative potential of bone marrow-derived mononuclear cells [MNCs] and CD133+ stem cells in the heart varies in terms of their pro-angiogenic effects. This phase II/III, multicenter and double-blind trial is designed to compare the functional effects of intramyocardial autologous transplantation of both cell types and placebo in patients with recent myocardial infarction [RMI] post-coronary artery bypass graft
Buscar no Google
Índice:
IMEMR (Mediterrâneo Oriental)
Tipo de estudo:
Ensaio Clínico Controlado
Idioma:
Inglês
Revista:
Cell J. [Yakhteh]
Ano de publicação:
2018
Similares
MEDLINE
...
LILACS
LIS